ID   LF-CL2A
AC   CVCL_2103
SY   LF Cl.2A; LFCl2A; LF clone 2A; Lafarge-Frayssinet clone 2A
DR   CLO; CLO_0007309
DR   CLDB; cl3204
DR   ChEMBL-Cells; CHEMBL3308563
DR   ChEMBL-Targets; CHEMBL614690
DR   DSMZ; ACC-195
DR   DSMZCellDive; ACC-195
DR   PubChem_Cell_line; CVCL_2103
DR   Wikidata; Q54902453
RX   PubMed=1309725;
CC   Doubling time: ~20-25 hours (DSMZ=ACC-195).
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar Commentry.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=1309725; DOI=10.1002/ijc.2910500213;
RA   Cassingena R., Lafarge-Frayssinet C., Frayssinet C., Nardeux P.-C.,
RA   Estrade S., Viegas-Pequignot E., Dutrillaux B.;
RT   "Spontaneous metastatic potential of rat hepatocarcinoma cells after
RT   cell fusion or DNA transfection.";
RL   Int. J. Cancer 50:238-245(1992).
//